Author of the publication

High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.

, , , , , , , , , , , , , , , , , and . Clin Cancer Res, 17 (15): 5082--5092 (August 2011)
DOI: 10.1158/1078-0432.CCR-10-2809

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers., , , , , , , , , and 27 other author(s). Clin Cancer Res, 21 (8): 1904-1915 (April 2015)Smoothing waves in array CGH tumor profiles., , , , , , , , , and . Bioinform., 25 (9): 1099-1104 (2009)RTPrimerDB: the Real-Time PCR primer and probe database., , , and . Nucleic Acids Res., 31 (1): 122-123 (2003)arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays., , , , , , , , , and 5 other author(s). BMC Bioinform., (2005)High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma., , , , , , , , , and 8 other author(s). Clin Cancer Res, 17 (15): 5082--5092 (August 2011)Translating expression profiling into a clinically feasible test to predict neuroblastoma outcome., , , , , , , , and . Clin Cancer Res, 13 (5): 1459--1465 (March 2007)Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature., , , , , , , , , and 10 other author(s). Clin Cancer Res, 16 (5): 1532--1541 (March 2010)Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers, , , , , , , , , and 27 other author(s). Clinical Cancer Research, (September 2014)